Skip to content

Application of percutaneous electrical stimulation combined with multimodal antiemetic in gynecological laparoscopic surgery

Application of percutaneous electrical stimulation combined with multimodal antiemetic in gynecological laparoscopic surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109253
Enrollment
Unknown
Registered
2025-09-16
Start date
2025-05-26
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative complications

Interventions

Group D:Dexamethasone 8 mg and droperidol 0.625 mg were given intraoperatively
Group T:30 minutes before anesthesia induction, transcutaneous acupuncture points were performed at both Hegu and Neiguan points until the operation was completed
Group D+T:Dexamethasone 8 mg and droperidol 0.625 mg were given intraoperatively
30 minutes before anesthesia induction, transcutaneous acupuncture points were performed at both Hegu and Neiguan points until the operation was completed

Sponsors

The Affiliated Hospital of Yangzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years old; 2. ASAI.-II. 3.BMI18.5-29.9kg/m^2; 4. No abnormal blood sugar; 5. Apfel score >= 2 points (i.e., female, non-smoker, history of motion sickness or PONV, at least 2 of the four items of postoperative use of opioid analgesics)

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to butyryl benzene; 2. Combined with severe liver, kidney and central nervous system diseases; 3. Patients treated with glucocorticoids; 4. Antiemetic drugs have been used within 24 hours before surgery; 5. Long-term use of analgesics; 6. Combined with severe hypertension and bradycardia; 7. Previous history of allergy to the use of anesthetic drugs; 8. Skin infection or damage at acupuncture points; 9. Those who cannot cooperate

Design outcomes

Primary

MeasureTime frame
The first occurrence time, frequency and severity of nausea and vomiting ;QoR15 score;patient satisfaction;

Secondary

MeasureTime frame
VAS score;Number of postoperative antiemetic medications;Time of first postoperative gas and getting out of bed;Postoperative complications occur;Remifentanil dosage;Intraoperative infusion volume;SBP, DBP, MAP, HR at the time of entry (T0), post-induction (T1), post-intubation (T2), 5 min after skin incision (T3), and post-operation (T4).;Number of analgesic medications;Duration of preoperative water fasting;From the end of the operation to the time of eating water;

Countries

China

Contacts

Public ContactJianyou Zhang

The Affiliated Hospital of Yangzhou University

zhangjianyou@yzu.edu.cn+86 138 1581 3811

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026